magnesium sulfate: be given to patients

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents salt
Weight: 0.73
, chemical compound
Weight: 0.67
, drug
Weight: 0.66
, treatment
Weight: 0.62
, mineral
Weight: 0.62
Siblings sodium sulfate
Weight: 0.41
, potassium sulfate
Weight: 0.40
, zinc sulfate
Weight: 0.40
, ammonium sulfate
Weight: 0.40
, sodium phosphate
Weight: 0.40

Related properties

Property Similarity
be given to patients 1.00
be given to preeclamptic patients 0.95
is given 0.77
be given in pregnancy 0.76
be given postpartum 0.76
be given for asthma 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.88
Similarity weight: 0.77
Evidence: 0.15
¬ Remarkable(magnesium sulfate, be given to patients)
Evidence: 0.77
¬ Remarkable(sodium phosphate, is given)

Remarkability from sibling implausibility

0.43
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.77
Remarkable(sodium phosphate, is given)
Evidence: 0.40
¬ Plausible(sodium phosphate, is given)

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.85
Similarity weight: 1.00
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.21
¬ Salient(magnesium sulfate, be given to patients)

Similarity expansion

0.70
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.95
Evidence: 0.15
Remarkable(magnesium sulfate, be given to patients)
Evidence: 0.16
¬ Remarkable(magnesium sulfate, be given to preeclamptic patients)
0.67
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.95
Evidence: 0.21
Salient(magnesium sulfate, be given to patients)
Evidence: 0.22
¬ Salient(magnesium sulfate, be given to preeclamptic patients)
0.64
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.95
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.30
¬ Plausible(magnesium sulfate, be given to preeclamptic patients)
0.64
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.03
¬ Plausible(magnesium sulfate, be given in pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.21
Salient(magnesium sulfate, be given to patients)
Evidence: 0.03
¬ Salient(magnesium sulfate, be given in pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.15
Remarkable(magnesium sulfate, be given to patients)
Evidence: 0.03
¬ Remarkable(magnesium sulfate, be given in pregnancy)
0.61
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.95
Evidence: 0.58
Typical(magnesium sulfate, be given to patients)
Evidence: 0.58
¬ Typical(magnesium sulfate, be given to preeclamptic patients)
0.59
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.76
Evidence: 0.58
Typical(magnesium sulfate, be given to patients)
Evidence: 0.20
¬ Typical(magnesium sulfate, be given in pregnancy)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.58
Typical(magnesium sulfate, be given to patients)
Evidence: 0.45
¬ Typical(magnesium sulfate, is given)
0.51
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.75
Evidence: 0.15
Remarkable(magnesium sulfate, be given to patients)
Evidence: 0.25
¬ Remarkable(magnesium sulfate, be given for asthma)
0.50
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.77
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.33
¬ Plausible(magnesium sulfate, is given)
0.50
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.77
Evidence: 0.21
Salient(magnesium sulfate, be given to patients)
Evidence: 0.29
¬ Salient(magnesium sulfate, is given)
0.47
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.75
Evidence: 0.21
Salient(magnesium sulfate, be given to patients)
Evidence: 0.34
¬ Salient(magnesium sulfate, be given for asthma)
0.47
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.76
Evidence: 0.15
Remarkable(magnesium sulfate, be given to patients)
Evidence: 0.32
¬ Remarkable(magnesium sulfate, be given postpartum)
0.46
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.77
Evidence: 0.15
Remarkable(magnesium sulfate, be given to patients)
Evidence: 0.34
¬ Remarkable(magnesium sulfate, is given)
0.45
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.75
Evidence: 0.58
Typical(magnesium sulfate, be given to patients)
Evidence: 0.70
¬ Typical(magnesium sulfate, be given for asthma)
0.45
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.76
Evidence: 0.58
Typical(magnesium sulfate, be given to patients)
Evidence: 0.72
¬ Typical(magnesium sulfate, be given postpartum)
0.43
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.75
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.47
¬ Plausible(magnesium sulfate, be given for asthma)
0.41
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.21
Salient(magnesium sulfate, be given to patients)
Evidence: 0.46
¬ Salient(magnesium sulfate, be given postpartum)
0.39
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.76
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.56
¬ Plausible(magnesium sulfate, be given postpartum)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.21
Salient(magnesium sulfate, be given to patients)
Evidence: 0.58
¬ Typical(magnesium sulfate, be given to patients)
Evidence: 0.15
¬ Remarkable(magnesium sulfate, be given to patients)

Typical implies Plausible

0.28
Rule weight: 0.48
Evidence weight: 0.59
Similarity weight: 1.00
Evidence: 0.29
Plausible(magnesium sulfate, be given to patients)
Evidence: 0.58
¬ Typical(magnesium sulfate, be given to patients)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.15
¬ Remarkable(magnesium sulfate, be given to patients)
Evidence: 0.32
¬ Typical(sodium phosphate, is given)